Abstract: Methods for passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, virions thereof, compositions and vaccines comprising such.
Type:
Application
Filed:
January 3, 2019
Publication date:
August 8, 2019
Applicant:
ALBERT EINSTEIN COLLGE OF MEDICINE, INC.
Abstract: Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, virions thereof, compositions and vaccines comprising such, and methods of use thereof are each provided.
Type:
Application
Filed:
June 1, 2018
Publication date:
April 18, 2019
Applicant:
ALBERT EINSTEIN COLLGE OF MEDICINE, INC.
Inventors:
William Jacobs, JR., Pablo A. Gonzalez-Munoz, Betsy Herold, Christopher Petro
Abstract: Provided are methods of treating an autoimmune disease in a subject, or of suppressing transplant rejection in a subject, or of treating a cancer in a subject, as well as compositions therefor.
Type:
Application
Filed:
September 5, 2018
Publication date:
January 10, 2019
Applicant:
ALBERT EINSTEIN COLLGE OF MEDICINE, INC.
Abstract: A method of reducing a cerebral tissue pathology associated with a sickle cell disease therapy in a subject is provided using (i) a synthetic high-oxygen affinity hemoglobin-containing molecule or (ii) synthetically treated high-oxygen affinity blood.
Type:
Application
Filed:
November 8, 2016
Publication date:
December 27, 2018
Applicant:
ALBERT EINSTEIN COLLGE OF MEDICINE, INC.
Abstract: Methods of treating a wound in a subject are provided comprising administering to the subject an amount of an inhibitor of Fidgetin-like 2. Compositions and pharmaceutical compositions comprising an amount of an inhibitor of Fidgetin-like 2 are also provided. Methods are also provided for identifying an inhibitor of Fidgetin-like 2.
Type:
Application
Filed:
March 12, 2018
Publication date:
July 19, 2018
Applicant:
ALBERT EINSTEIN COLLGE OF MEDICINE, INC.